Clinical Trial: Esketamine Combined With Dexmedetomidine Sedation in Head MRI Examination of Children With Autism Spectrum Disorder
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Autism Spectrum Disorder
Study Type: INTERVENTIONAL
Official Title: Application of Ketamine Combined With Dexmedetomidine Sedation in Magnetic Resonance Imaging of Children With Autism and Autism Spectrum Disorder:a-Randomized Controlled Trial
Brief Summary:
Objective: To investigate the use of ketamine combined with dexmedetomidine for sedation in children with autism spectrum disorder, Methods:aged 2-6 years,, ASA grade I or II.The children were randomly divided into three groups using a random number table method: a low-dose dexmedetomidine group (DEXL group,n=100?The high-dose group of dexmedetomidine (DEXH group,n=100) and the group of esketamine combined with dexmedetomidine (DEXE group,n=100).The DEXL group received 2.5 ? g/kg of dexmedetomidine nasal…
Read more